Status:
UNKNOWN
Digital Variance Angiography for Contrast Media Dose Reduction in Carotid Artery Stenting
Lead Sponsor:
Kinepict Health Ltd.
Collaborating Sponsors:
Semmelweis University
Bács-Kiskun County Teaching Hospital
Conditions:
Carotid Artery Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Digital Variance Angiography (DVA) is a new tool in medical imaging with a proven image quality reserve (1, 2). Previous studies have demonstrated the quality reserve of DVA in angiographic studies (...
Eligibility Criteria
Inclusion
- Age \> 18 y
- Carotid stenosis defined as:
- Stenosis ≥70% by computer tomography angiography (NASCET criteria); OR by duplex-ultrasound with ≥70% stenosis defined by a peak systolic velocity of at least 230 cm/s
- Carotid stenosis is treatable with CAS
Exclusion
- History of stroke or TIA ipsilateral to the stenosis within 30 days of randomization
- Acute myocardial infarction
- Severe chronic kidney disease: GFR\>30ml/min/m2
- Severe heart failure: NYHA IV
- Severe liver failure: Child-Pugh 3
- Iodine contrast allergy
- Coagulopathy
- Hematological bleeding disorders
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04792255
Start Date
June 1 2022
End Date
December 31 2023
Last Update
March 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Semmelweis University, Heart and Vascular Center
Budapest, Hungary, 1122